“Those with MS in Canada and several other countries are able to use Sativex to treat painful and difficults plasticity. But because Sativex contains real cannabis, MS patients in the US aren't allowed to be treated. This, even though their own National Academies of Science, Engineering, and Medicine report on the conclusive and substantial evidence of cannabis benefits specifically for spasticity in MS.”
- Dr. David Hepburn
Theaimwas to examine evolution in activities of daily living (ADL) in patients with multiple sclerosis spasticity during long-term use of tetrahydrocannabinol (THC): cannabidiol (CBD) oromucosal spray.
In this pilot study, THC: CBD oromucosal spray maintained or improved aspects of daily functioning. Further study in a larger trial is warranted.
Read the full article here:
https://www.ncbi.nlm.nih.gov/pubmed/29851356
Visit
Dr. Dave Hepburn website: https://doctordavidhepburn.com
0 comments:
Post a Comment